SI0764172T1 - Sintetski peptidni analogi pljučnega surfaktantskega proteina SP-C - Google Patents

Sintetski peptidni analogi pljučnega surfaktantskega proteina SP-C

Info

Publication number
SI0764172T1
SI0764172T1 SI9530712T SI9530712T SI0764172T1 SI 0764172 T1 SI0764172 T1 SI 0764172T1 SI 9530712 T SI9530712 T SI 9530712T SI 9530712 T SI9530712 T SI 9530712T SI 0764172 T1 SI0764172 T1 SI 0764172T1
Authority
SI
Slovenia
Prior art keywords
pct
image
surfactant protein
lung surfactant
synthetic peptide
Prior art date
Application number
SI9530712T
Other languages
English (en)
Inventor
R�diger NAVE
Wolf-R�diger ULRICH
Ernst Sturm
Uwe KR�GER
Dietrich H�FNER
Klaus P. SCH�FER
Klaus Melchers
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6519392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0764172(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI0764172T1 publication Critical patent/SI0764172T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
SI9530712T 1994-05-31 1995-05-27 Sintetski peptidni analogi pljučnega surfaktantskega proteina SP-C SI0764172T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4418936A DE4418936A1 (de) 1994-05-31 1994-05-31 Polypeptid
PCT/EP1995/002028 WO1995032992A1 (de) 1994-05-31 1995-05-27 Synthetische peptidanaloge des lungenoberflächenproteins sp-c
EP95920906A EP0764172B1 (de) 1994-05-31 1995-05-27 Synthetische peptidanaloge des lungenoberflächenproteins sp-c

Publications (1)

Publication Number Publication Date
SI0764172T1 true SI0764172T1 (sl) 2005-02-28

Family

ID=6519392

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530712T SI0764172T1 (sl) 1994-05-31 1995-05-27 Sintetski peptidni analogi pljučnega surfaktantskega proteina SP-C

Country Status (29)

Country Link
US (1) US5874406A (sl)
EP (1) EP0764172B1 (sl)
JP (1) JP3359638B2 (sl)
KR (1) KR100355626B1 (sl)
CN (1) CN1130374C (sl)
AT (1) ATE275154T1 (sl)
AU (1) AU690280B2 (sl)
BG (1) BG63210B1 (sl)
BR (1) BR9507811B1 (sl)
CA (1) CA2191344C (sl)
CY (1) CY2552B1 (sl)
CZ (1) CZ286976B6 (sl)
DE (2) DE4418936A1 (sl)
DK (1) DK0764172T3 (sl)
EE (1) EE03775B1 (sl)
ES (1) ES2227548T3 (sl)
FI (1) FI118126B (sl)
HK (1) HK1000891A1 (sl)
HU (1) HU220191B (sl)
NO (1) NO317149B1 (sl)
NZ (1) NZ287447A (sl)
PL (1) PL181234B1 (sl)
PT (1) PT764172E (sl)
RO (1) RO118752B1 (sl)
RU (1) RU2145611C1 (sl)
SI (1) SI0764172T1 (sl)
SK (1) SK282441B6 (sl)
UA (1) UA35636C2 (sl)
WO (1) WO1995032992A1 (sl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035882A1 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
DE19851119C2 (de) 1998-11-06 2001-05-31 Byk Gulden Lomberg Chem Fab Behälter und Vorrichtung zur Blindung der Verabreichung von nicht festen pharmazeutischen Darreichungsformen bei der klinischen Prüfung
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
JP2003501481A (ja) * 1999-06-11 2003-01-14 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング サーファクタントタンパク質ｂ（ｓｐ−ｂ）改変体およびサーファクタントタンパク質ｃ（ｓｐ−ｃ）改変体を含有する医薬品製剤
PT1192184E (pt) 1999-06-17 2007-03-30 Altana Pharma Ag Ésteres de proteína c surfactantes
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
WO2001039573A2 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von lungensurfactant zur behandlung von legionärskrankheit
CA2399944A1 (en) * 2000-02-11 2001-08-16 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
US6660833B1 (en) * 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
EP1276495B1 (en) * 2000-04-12 2006-04-19 ALTANA Pharma AG Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
CA2463459C (en) 2001-10-11 2013-06-18 Altana Pharma Ag Novel use of pulmonary surfactant
WO2003053455A1 (en) 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
WO2006013183A1 (en) 2004-08-06 2006-02-09 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
ATE538814T1 (de) 2005-01-06 2012-01-15 Discovery Lab Inc Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien
DE102005014650B3 (de) 2005-03-31 2006-08-17 Altana Pharma Ag Anordnung aus Katheter und Anschlussstück sowie Ventil zum Durchführen eines Katheters
DE102005016229B3 (de) 2005-04-08 2006-06-14 Altana Pharma Ag Trockenvernebler
CA2663795A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
US9289388B2 (en) 2008-12-10 2016-03-22 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
KR101767693B1 (ko) 2009-09-08 2017-08-23 키에시 파르마슈티시 엣스. 피. 에이. 폐 계면 활성제와 항산화 효소를 포함하는 치료용 혼합물
EA201300255A1 (ru) * 2010-08-23 2013-06-28 Такеда Гмбх Увлажненные частицы, содержащие терапевтически активное вещество
US9815869B2 (en) * 2012-02-09 2017-11-14 University Of Rochester SP-B and SP-C peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
KR102369135B1 (ko) 2014-03-05 2022-02-28 프라운호퍼-게젤샤프트 추르 푀르데룽 데어 안제반텐 포르슝 에 파우 에어로졸을 가습하기 위한 가습기
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
CN107666933A (zh) 2015-04-22 2018-02-06 奇斯药制品公司 用于药物有效地呼吸同步递送到肺部的方法和系统
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
US20180147262A1 (en) * 2015-04-30 2018-05-31 University Of Bremen Novel skin medical and cosmetic care product
BR112019001470A2 (pt) 2016-07-28 2019-05-07 Chiesi Farm Spa sistema para entregar um medicamento aerossolizado, frasco, kit e surfactante pulmonar
ES2892903T3 (es) 2016-10-26 2022-02-07 Chiesi Farm Spa Dispositivo para facilitar la administración de un medicamento a los pulmones por medio de un catéter
MX2019006263A (es) 2016-12-22 2019-08-21 Chiesi Farm Spa Combinacion terapeutica que comprende un tensioactivo pulmonar y un esteroide para el tratamiento de displasia broncopulmonar (bpd) en evolucion.
CN107163148A (zh) * 2017-05-15 2017-09-15 重庆理工大学 肺表面活性蛋白b前肽的重组蛋白及其制备方法和应用
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
KR20210005614A (ko) 2018-04-23 2021-01-14 키에시 파르마슈티시 엣스. 피. 에이. Bpd의 예방을 위한 폐 계면활성제 및 스테로이드를 포함하는 치료학적 조합물
CN109001466A (zh) * 2018-07-19 2018-12-14 新疆维吾尔自治区人民医院 一种用于osa的肺表面活性蛋白试剂盒及其应用
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
WO1989004326A1 (en) * 1987-11-04 1989-05-18 California Biotechnology Inc. Alveolar surfactant proteins
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
MX9605986A (es) 1998-06-30
PT764172E (pt) 2005-01-31
WO1995032992A1 (de) 1995-12-07
FI118126B (fi) 2007-07-13
DE59510941D1 (de) 2004-10-07
ES2227548T3 (es) 2005-04-01
RU2145611C1 (ru) 2000-02-20
SK152496A3 (en) 1997-06-04
SK282441B6 (sk) 2002-02-05
US5874406A (en) 1999-02-23
AU2616995A (en) 1995-12-21
CN1154117A (zh) 1997-07-09
CA2191344C (en) 2003-04-08
FI964766A0 (fi) 1996-11-29
CN1130374C (zh) 2003-12-10
KR100355626B1 (ko) 2002-12-26
DE4418936A1 (de) 1996-02-08
NZ287447A (en) 1998-01-26
NO965052D0 (no) 1996-11-27
BG101028A (en) 1998-01-30
PL317420A1 (en) 1997-04-14
HU9603249D0 (en) 1997-01-28
PL181234B1 (pl) 2001-06-29
JPH10504025A (ja) 1998-04-14
AU690280B2 (en) 1998-04-23
FI964766A (fi) 1996-11-29
CZ286976B6 (en) 2000-08-16
BG63210B1 (bg) 2001-06-29
EP0764172B1 (de) 2004-09-01
UA35636C2 (uk) 2001-04-16
NO317149B1 (no) 2004-08-30
CA2191344A1 (en) 1995-12-07
ATE275154T1 (de) 2004-09-15
CZ350296A3 (en) 1997-05-14
HUT76952A (hu) 1998-01-28
JP3359638B2 (ja) 2002-12-24
BR9507811A (pt) 1997-09-16
CY2552B1 (en) 2008-07-02
EP0764172A1 (de) 1997-03-26
DK0764172T3 (da) 2005-01-10
BR9507811B1 (pt) 2009-05-05
KR970703367A (ko) 1997-07-03
RO118752B1 (ro) 2003-10-30
EE03775B1 (et) 2002-06-17
HU220191B (hu) 2001-11-28
HK1000891A1 (en) 2004-09-17
NO965052L (no) 1997-01-28
EE9600175A (et) 1997-06-16

Similar Documents

Publication Publication Date Title
CY2552B1 (en) Synthetic peptide analogs of lung surfactant protein SP-C
AU4188789A (en) Urethane-protected amino acid-n-carboxyanhydrides
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
CA2024651A1 (en) High-absorbable transvaginal preparation containing biologically active polypeptide
TR199501630A2 (tr) Peptid p277 benzerleri ve diagnoz ve dibetlerin'lerin tedavisi icin onlari iceren kompozisyonlar.
GR852541B (sl)
DE3569541D1 (en) Pharmacologically active peptides
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
IL111196A0 (en) Peptides and pharmaceutical compositions comprising them
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
AU7052191A (en) Antitumoral composition based on polypeptides having human interleukin 2 activity
JPS649938A (en) Oral ingestive composition
CA2004764A1 (en) Ancrod proteins, their preparation and use
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
AU7627987A (en) Use of 2-aminoalkyl-5-pyridinols as nootropic agents and anti-depressants
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
ATE82504T1 (de) Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie.
JPS6423899A (en) Novel physiologically active polypeptide